Terug
Dagbereik
€ 28,37
€ 29,92
52-Weeksbereik
€ 4,30
€ 40,37
Volume
1.096.652
50D / 200D Gem.
€ 26,28
/
€ 14,68
Vorige Slotkoers
€ 30,10
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -12,6 | 0,3 |
| P/B | 4,3 | 2,9 |
| ROE % | -46,6 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 47,75
+65.4%
Low: € 13,00
High: € 62,00
Forward K/W
154,4
Forward WPA
€ 0,20
WPA Groei (sch.)
+0,0%
Omzet Sch.
150 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,31
-€ 1,43 – € 15,11
|
680 M | 1 |
| FY2029 |
€ 4,03
-€ 0,91 – € 9,65
|
450 M | 1 |
| FY2028 |
€ 2,04
€ 1,04 – € 4,94
|
280 M | 5 |
Belangrijkste Punten
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -72,72B
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-46,56%
ROIC-24,82%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,07
Current Ratio9,01
Interest Coverage-35,51
Waardering
P/E Ratio
-12,56
P/B Ratio4,32
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -105,04M |
| ROE | -46,56% | ROA | -29,51% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -72,72B |
| ROIC | -24,82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 9,01 |
| Interest Coverage | -35,51 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -12,56 | P/B Ratio | 4,32 |
| P/S Ratio | N/A | PEG Ratio | -0,13 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,32B | Enterprise Value | 1,05B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 22,27M | 25,18M | 2,55M | 244.898,0 |
| Net Income | -105,04M | -40,47M | -22,29M | -29,02M | -20,02M |
| EPS (Diluted) | -2,26 | -1,15 | -0,83 | -1,18 | -0,87 |
| Gross Profit | 0,0 | -27,70M | -11,27M | -19,27M | 244.898,0 |
| Operating Income | -108,14M | -42,56M | -24,08M | -29,70M | -20,94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 355,95M | 170,48M | 58,73M | 50,09M | 41,33M |
| Total Liabilities | 50,16M | 25,02M | 36,13M | 38,31M | 9,96M |
| Shareholders' Equity | 305,79M | 145,46M | 22,60M | 11,79M | 31,37M |
| Total Debt | 20,94M | 1,45M | 2,24M | 2,56M | 2,87M |
| Cash & Equivalents | 287,85M | 11,29M | 14,69M | 9,60M | 34,89M |
| Current Assets | 322,94M | 163,39M | 50,86M | 42,89M | 36,44M |
| Current Liabilities | 35,84M | 21,03M | 31,27M | 23,59M | 4,13M |